HanAll Biopharma

News

Immunovant shares were sliding today after it reported that FcRn blocker batoclimab failed a pair of phase 3 trials in thyroid eye disease.

News

Insmed is working with a bronchiectasis patient organisation on a real-world trial of Brinsupri, the first FDA-approved drug for the lung disorder.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.